In the complex landscape of laboratory and diagnostic test reimbursement, it can be difficult to understand how best to pursue coding and payment strategies for new tests when working across various government and private payers. One straightforward approach is to...
Disclaimer: This blog is a marketing piece designed to promote our services and provide general information about Stark Law. It is not intended to serve as a legal document or legal guidance for Stark Law compliance. Please be advised that this blog was revised on...
By: Cassie Penn, Client Manager, Lighthouse Lab Services Laboratories have been in a whirlwind since the COVID pandemic started in 2019. Now that we have reached the end of the pandemic and the Public Health Emergency, laboratories need to work on tightening up their...
By: Ann Lambrix, VP of RCM Consulting, Lighthouse Lab Services. About this article: Our monthly “RCM Industry Spotlight” series highlights timely findings from Lighthouse’s proprietary RCM Spotlight denial management tool. If you’d like to...
By: Tara Luellen, VP of Lab Director Services, Lighthouse Lab Services New York State recently proposed several amendments to regulations regarding laboratory directors (LDs), including moves that would impact the number of laboratories they can oversee and the...
Toxicology labs and pain management providers should be on alert for the combination of fentanyl and xylazine after the White House recently designated the mixture of these drugs as an emerging threat to the United States. Xylazine, also known as tranq or tranq dope,...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy